NPI | Name | Type | Address |
---|---|---|---|
Lee Ann Mcclannan |
Individual |
989200 Nebraska Medicine Campus Zip 1090 Omaha, NE |
|
PHARMD Jessica Lynn Bankston |
Individual |
2500 Starling St Ste 303 Brunswick, GA |
|
PHARMD Huei-li Lily Barker |
Individual |
2620 Chester Ave Bakersfield, CA |
|
Chao Yuan Ku |
Individual |
505 S 45th St Omaha, NE |
|
DR. PHARMD Thomas Lloyd Davis |
Individual |
111 N 175th St Omaha, NE |
|
DR. PHARMD Rob Swaney |
Individual |
2500 Bellevue Medical Center Dr Bellevue, NE |
|
PHARMD William Tillett |
Individual |
2500 Starling St Ste 303 Brunswick, GA |
|
PHARMD Jared Matya |
Individual |
988149 Nebraska Medical Ctr Omaha, NE |
|
PHARMD, BCPS, BCOP Ashley Sant |
Individual |
1 Professional Park Dr Ste 21 Johnson City, TN |
|
Seema Patel |
Individual |
9500 Euclid Ave Cleveland, OH |
|
Ashley Mary Kenkel |
Individual |
505 S 45th St Omaha, NE |
|
DR. PHARMD Sarah Emily Medeiros |
Individual |
981090 Nebraska Medical Ctr Omaha, NE |
|
DR. PHARMD Michael B Hardler JR. |
Individual |
100 N Academy Ave Danville, PA |
|
Kealy Marth |
Individual |
987400 Nebraska Medical Ctr Omaha, NE |
|
PHARMD Sonja Jacobsen |
Individual |
747 Broadway Seattle, WA |
|
PHARMD Jessica Sobczyk |
Individual |
989200 Nebraska Medical Ctr Omaha, NE |
|
PHARMD Spencer Lehmann |
Individual |
989200 Nebraska Med Center Omaha, NE |
|
Amy Mayer |
Individual |
989200 Nebraska Medical Canter Omaha, NE |
|
PHARMD Veronica Ramirez |
Individual |
989200 Nebraska Medical Ctr Omaha, NE |
|
DR. PHARMD Andrew Harold Clark |
Individual |
111 Michigan Ave Nw Washington, DC |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |